Detection of Adalimumab and Anti-Adalimumab Levels by ELISA: Clinical Considerations-Reference-Cited by-同舟云学术

Detection of Adalimumab and Anti-Adalimumab Levels by ELISA: Clinical Considerations

Published:2014-11 Issue: Volume:75 Page:S11-S14
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Marinari Barbara¹²,Botti Elisabetta¹²,Bavetta Mauro³,Spallone Giulia²³,Zangrilli Arianna³,Talamonti Marina³,Richetta Antonio⁴,Chimenti Sergio³,Costanzo Antonio¹²

Affiliation:

1. Dermatology Unit; NESMOS Department; Sapienza University of Rome; Rome Italy

2. Skin Biology Laboratory; Tor Vergata University of Rome; Rome Italy

3. Department of Dermatology; Tor Vergata University of Rome; Rome Italy

4. Dermatology Unit; Medical Specialties Department; Sapienza University of Rome; Rome Italy

Publisher

Wiley

Subject

Drug Discovery

Reference6 articles.

1. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey;Aggarwal;Blood,2012

2. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up;Bartelds;JAMA,2011

3. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis;Bartelds;Ann Rheum Dis,2007

4. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease;Karmiris;Gastroenterology,2009

5. The concept of psoriasis as a systemic inflammation: implications for disease management;Reich;J Eur Acad Dermatol Venereol,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing the thiol chemistry of biomolecules for the rapid determination of anti-TNF-α drug in blood;Talanta;2020-02

2. Current standardized therapeutic approach for uveitis in Japan;Immunological Medicine;2019-07-03

3. Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn’s Disease;Inflammatory Bowel Diseases;2019-02-18

4. Pharmacotherapeutic strategies for standard treatment-resistant psoriasis;Expert Opinion on Pharmacotherapy;2018-12-27

5. Recent advances in mass spectrometry-based approaches for proteomics and biologics: Great contribution for developing therapeutic antibodies;Pharmacology & Therapeutics;2018-05